Who Owns Nexcare?

Nexcare operates under Solventum Corporation's sustainability framework, which focuses on environmental stewardship, social impact, and circular economy principles.

Climate Action: Solventum is committed to achieving net-zero greenhouse gas emissions by 2050 and sourcing 100% renewable electricity by 2030. As of 2024, the company had reduced Scope 1 and 2 emissions by 21.9% since 2021 and transitioned 10 manufacturing sites to renewable electricity.

Zero Landfill and Waste Reduction: Solventum has achieved zero landfill status at 56.5% of its manufacturing sites. The company's Health Care Service Center supports circular economy principles by keeping healthcare products in working condition instead of in landfills.

Energy Efficiency: Two flagship Solventum sites are cutting over 2,000 metric tons of CO2e by 2025 through enhanced energy efficiency initiatives. Nexcare production facilities participate in these programs.

Social Impact: Solventum donated more than $1.2 million to nonprofit partners in 2024, supporting community health initiatives. The company launched the Solventum Cares Assistance Fund for employees facing hardship.

Global Health Access: Solventum funded preventive dental care for more than 2,000 children in rural areas through a partnership with the China Oral Health Foundation, demonstrating commitment to expanding global access to healthcare services.

Technology Innovation: Nexcare has been acknowledged for its adhesive bandage and wound care technology, particularly for waterproofing capabilities, flexible fabric construction, and sensitive skin formulations. The brand's products offer performance advantages over conventional bandages.

Market Leadership: Nexcare holds the position of second-largest brand in the U.S. adhesive bandage market, with an estimated 15% to 20% market share behind Band-Aid. This represents significant success in a category dominated by a century-old brand.

Product Performance Recognition: Nexcare products have received recognition from healthcare professionals and consumer testing organizations for superior waterproofing, adhesion strength, and flexibility.

Global Expansion: Nexcare's presence in over 100 countries demonstrates successful global expansion and market penetration, adapting products for different healthcare systems and consumer preferences.

FDA Adverse Event Reporting: Nexcare products have been subject to FDA adverse event reporting through the MAUDE database, including reports related to Nexcare Tegaderm + Pad dressings and waterproof bandages. Most reports involve minor skin irritation or allergic reactions.

Allergic Reactions: Some consumers have reported allergic reactions or skin sensitivity to Nexcare adhesive products, particularly waterproof bandages with enhanced adhesive formulations. These typically involve mild to moderate skin irritation or contact dermatitis, common with adhesive medical products.

Regulatory Compliance: As a medical device manufacturer, Nexcare operates under strict FDA and international regulatory requirements. The brand maintains comprehensive quality control systems and adverse event monitoring programs.

Competitive Pressure: Nexcare faces intense competition from Band-Aid, which dominates the market with over 80% share. This pressure creates challenges for market expansion, particularly in retail environments where private label brands compete on price.

Spinoff Transition: The transition from 3M's corporate structure to Solventum's independent structure in 2024 created potential supply chain and distribution challenges. Integration risks required careful management to maintain product availability during the corporate transition.